Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,261,690
+$853,952 QoQ
Shares Held
7,486
+130.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#365
of 768 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
105,781 | $8,433,919 | |
| 2 | HROW |
Harrow, Inc.
|
116,908 | $4,965,082 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
73,101 | $2,646,256 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26,976 | $2,233,073 | |
| 5 | DERM |
Journey Medical Corp
|
295,663 | $2,093,294 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
7,486 | $1,261,690 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,972 | $218,773 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,261,690 | 7,486 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $407,738 | 3,244 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $349,827 | 3,163 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||